August 1, 2017

The TEH-TUBE consortium has reached a significant milestone in its objectives to create a bioresorbable valved tube for the potential treatment of RVOT. The first implantation of our novel bioresorbable valved tube has been undertaken in France. The implanted valved tube is functioning and we are confident that this is an important step towards achieving...

Please reload


The TEH-TUBE project has been partially funded by the European Union Seventh Framework Programme (FP7)

© Copyright TEH-TUBE consortium 2017